Načítá se...

Immune modulatory nanoparticle therapeutics for intracerebral glioma

BACKGROUND. Previously we showed therapeutic efficacy of unprotected miR-124 in preclinical murine models of glioblastoma, including in heterogeneous genetically engineered murine models by exploiting the immune system and thereby negating the need for direct tumor delivery. Although these data were...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Yaghi, Nasser K., Wei, Jun, Hashimoto, Yuuri, Kong, Ling-Yuan, Gabrusiewicz, Konrad, Nduom, Edjah K., Ling, Xiaoyang, Huang, Neal, Zhou, Shouhao, Kerrigan, Brittany C. Parker, Levine, Jonathan M., Fajt, Virginia R., Levine, Gwendolyn, Porter, Brian F., Marcusson, Eric G., Tachikawa, Kiyoshi, Chivukula, Padmanabh, Webb, David C., Payne, Joseph E., Heimberger, Amy B.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464307/
https://ncbi.nlm.nih.gov/pubmed/27765835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now198
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!